Overview

Physicians' Health Study

Status:
Completed

Trial end date:
1996-12-01

Target enrollment:

Participant gender:

Summary

To assess the effect on cardiovascular mortality of alternate-day consumption of 325 milligrams of aspirin and, secondarily, the effect on cancer incidence of alternate-day consumption of 50 milligrams of beta-carotene.

Phase:

Phase 3

Details

Lead Sponsor:

Brigham and Women's Hospital

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Aspirin
Carotenoids